Doceree, the world’s physician-only platform for programmatic messaging, has secured $35 million in a Series B funding round, with Creaegis, a distinguished digital and technology investment firm, taking the lead. This funding marks a significant milestone for Doceree, with continued support from existing investors Eight Roads Ventures and F-Prime Capital. The capital infusion will be instrumental in driving product and technology development and furthering global expansion efforts aimed at transforming communications with healthcare professionals (HCPs), as stated by the company. Investec played a crucial role as the advisor for Doceree during the Series B transaction.

Founded in 2019 by prominent healthcare marketing professionals Harshit Jain and Daleep Manhas, Doceree has positioned itself as a solution to the challenge of rising healthcare costs. The company leverages data and creativity in healthcare marketing to enhance efficiency and effectiveness in physician engagement. Doceree empowers pharmaceutical and life sciences companies, along with healthcare media agencies, by providing solutions that seamlessly reach HCPs through their networks and digital workflows, ultimately contributing to improved patient health outcomes.

In the previous year, Doceree raised $11 million in a Series A round led by Eight Roads Ventures, a global investment firm affiliated with Fidelity. F-Prime Capital and Alkemi Growth Capital were also participants in this round. Boasting the status of the largest global network of HCP-only digital platforms, headquartered in New Jersey, Doceree has rapidly transformed HCP communications through its programmatic messaging capabilities. These capabilities enable clients worldwide to optimize the performance of their physician engagement initiatives.

Harshit Jain MD, Founder and Global CEO of Doceree, expressed his thoughts on the achievement, stating, “We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targeting solutions that have helped our clients succeed with profitable growth. The pharma messaging space is evolving at a fast pace, and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space. We are growing massively and have a competitive edge. We are thrilled about the future as we continue to expand and touch new horizons in the space.”

Creaegis Managing Partner and CIO Prakash Parthasarathy, along with Partner Nitish Bandi, expressed their excitement about partnering with Doceree. They emphasized Doceree’s industry-leading digital platform driven by deep learning-based data models, which will lead the company into its next phase of growth. With a presence in the United States, India, and European markets, Doceree has broadened its reach to Africa, Southeast Asia (SEA), and the Gulf Cooperation Council (GCC).